An observational study in Infertility (IVF Patients) and Success Rate, sponsored by Universitätsklinik fur Frauenheilkunde, Inselspital Bern. Recruiting at 1 site in Switzerland. Open to female participants aged 18 Years to 44 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Universitätsklinik fur Frauenheilkunde, Inselspital Bern · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Infertility with a site in Switzerland — 7 open to participants now, 8 under way, 1 of them phase 3. Infertility · Switzerland.
Among the 25 studies in Infertility with a site in Switzerland, this one is the 5th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2026, is one of 10 observational ones, and was the 25th registered.
2,089 studies on the registry are indexed under Infertility; 356 are open to participants now.
Browse Infertility studies →7 of the 25 studies in Infertility with a site in Switzerland are open now. Recruiting first, the newest first:
BEYOND GENOMiX SA, AG, Ltd · Sites in Switzerland
Ages 25–42 · Women only
Swiss GO Trial Group · Sites in Switzerland, Belgium, Poland and 1 more country
Ages 18+ · Women only · Healthy volunteers
Michael von Wolff · Sites in Switzerland
Ages 14–50
Janna Pape · Sites in Switzerland
Ages 18–42
Georgios Papadakis · Sites in Switzerland
Ages 16–65 · Men only
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 234 Infertility studies recruiting now, 43 (18%) set no upper age limit and 185 (79%) stop at 75 or younger; 27 take children under 18; 76 take healthy volunteers.
This study: 18 Years to 44 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 200 across 591 observational studies indexed under Infertility.
Median enrollment 200 across the 15 interventional studies, 250 across the 10 observational. Of the 15 that completed or were terminated, 6 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 25 have an industry lead sponsor. The 10 most frequent:
Universitätsklinik fur Frauenheilkunde, Inselspital Bern is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Universitätsklinik fur Frauenheilkunde, Inselspital Bern has 1 study filed under Infertility — fewer than ten, so there is no comparison to draw.
2 of the studies in Infertility with a site in Switzerland that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05586802Phase 3Georgios PapadakisSex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome | 2027-04-30 |
| NCT07938736Universitätsklinik fur Frauenheilkunde, Inselspital BernQuality of Life, Decision-making, Resilience, Satisfaction and Success Rate of Different IVF Treatment Strategies: an International Prospective Cohort Study | 2027-05-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 25 studies in Infertility with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Study aims to assess the quality of life and mental health of patients suffering from infertility. Secondly, this study aims to discover the true reasons for choosing a certain IVF treatment (whether quality of life related or otherwise) and the extent to which defined factors (e.g. cost, doctor recommendations, stress levels and effectiveness) influence this choice. Thirdly, the study aims to examine psychological resilience in adhering to a treatment choice and the reasons for changing treatment. Finally, we will evaluate the cumulative live birth rate over a planned timeframe, including that experienced with IVF Naturelle, as these are currently unknown.
The project population consists IVF patients who are willing to participate in this study. Patients should not have had an IVF treatment before or, if a clinical pregnancy had been achieved by IVF, a new IVF therapy should not have started since then.
After receiving advice on the advantages and disadvantages of each type of in vitro fertilisation treatment (NC/ Min-stim IVF and cIVF strategy), couples will be free to decide which IVF treatment strategy they wish to follow. Couple are also free to change treatment strategy during the 6 month treatment phase.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
NC-/Min Stim IVF
cIVF
NC-/Min Stim IVF and cIVF
Quality of life
Quality of life related to infertility will be analyzed using the Fertility Quality of Life (FertiQoL) questionnaire. The FertiQoL questionnaire contains 36 items in total, assessing the personal and interpersonal impact, quality of life specifically related to medical interventions, and general self-rated health and quality of life. Scores on the response scales are reversed, summed and scaled to range from 0 to 100. Higher scores on the subscales and total scores indicate better quality of life.
Time frame: 6 months
Mental Health
Mental health related to infertility will be analyzed using the Center for Epidemiologic Studies Depression Scale (CES-D) scale. The standard CES-D is a 20-item self-report questionnaire assessing depressive symptoms experienced over the past week. Scores range between 0 to 60. Higher scores indicate greater severity and frequency of depressive symptoms.
Time frame: 6 months
Factors first choice of IVF
Which factors have affected your first choice of IVF treatment strategy?
Time frame: 6 months
Success rate
Number of pregnancies (clinical/ongoing), any live birth (defined as at least one delivery of a live infant resulting from all NC/Min stim-IVF, cIVF or mixed treatment cycles, inclusive frozen embryo transfer (FET) cycles until pregnancy occurred or until 6 months were over). Type of IVF (in each cycle): NC-, Min stim- and cIVF Number of miscarriages Number of ectopic pregnancies, others outcome of pregnancy Number of women who discontinue IVF treatment Premature ovulation: yes/no Number of oocytes, zygotes, embryos and frozen embryos (inclusive day of freezing) Preimplantation Genetic Testing (PGT) (yes or no) Technology of fertilization (IVF or ICSI or both) Day of embryo transfer (2, 3 or 5) Number of transferred embryos Number of frozen embryos remaining at the end of the six-month observation period (inclusive day of freezing)
Time frame: 6 months
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Jun 2026 (actual). Primary completion is estimated for May 2027, 11 months after the start.
Of 209 non-industry observational studies under Infertility, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 100. This study's planned 11 months is below that.
Counting every sponsor, half of 240 studies reached it within 39 months; a quarter within 16 and three quarters within 99.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitätsklinik fur Frauenheilkunde, Inselspital Bern